AU2014233048B2 - Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders - Google Patents

Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders Download PDF

Info

Publication number
AU2014233048B2
AU2014233048B2 AU2014233048A AU2014233048A AU2014233048B2 AU 2014233048 B2 AU2014233048 B2 AU 2014233048B2 AU 2014233048 A AU2014233048 A AU 2014233048A AU 2014233048 A AU2014233048 A AU 2014233048A AU 2014233048 B2 AU2014233048 B2 AU 2014233048B2
Authority
AU
Australia
Prior art keywords
subject
asd
activity
stimulus
age
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014233048A
Other languages
English (en)
Other versions
AU2014233048A1 (en
Inventor
James Christopher EDGAR
Timothy P.L. Roberts
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Childrens Hospital of Philadelphia CHOP
Original Assignee
Childrens Hospital of Philadelphia CHOP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Childrens Hospital of Philadelphia CHOP filed Critical Childrens Hospital of Philadelphia CHOP
Publication of AU2014233048A1 publication Critical patent/AU2014233048A1/en
Application granted granted Critical
Publication of AU2014233048B2 publication Critical patent/AU2014233048B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4848—Monitoring or testing the effects of treatment, e.g. of medication
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/24—Detecting, measuring or recording bioelectric or biomagnetic signals of the body or parts thereof
    • A61B5/242—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents
    • A61B5/245—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals
    • A61B5/246—Detecting biomagnetic fields, e.g. magnetic fields produced by bioelectric currents specially adapted for magnetoencephalographic [MEG] signals using evoked responses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/40—Detecting, measuring or recording for evaluating the nervous system
    • A61B5/4076—Diagnosing or monitoring particular conditions of the nervous system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medical Informatics (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • Neurology (AREA)
  • Physiology (AREA)
  • Neurosurgery (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AU2014233048A 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders Active AU2014233048B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361787077P 2013-03-15 2013-03-15
US61/787,077 2013-03-15
PCT/US2014/030138 WO2014145382A2 (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of gaba-b agonist drug activity in autism spectrum disorders

Publications (2)

Publication Number Publication Date
AU2014233048A1 AU2014233048A1 (en) 2015-10-08
AU2014233048B2 true AU2014233048B2 (en) 2019-01-03

Family

ID=51538466

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014233048A Active AU2014233048B2 (en) 2013-03-15 2014-03-17 Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders

Country Status (6)

Country Link
US (1) US10342480B2 (https=)
EP (1) EP2967405A4 (https=)
JP (1) JP6585030B2 (https=)
AU (1) AU2014233048B2 (https=)
CA (1) CA2907494C (https=)
WO (1) WO2014145382A2 (https=)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018194959A1 (en) * 2017-04-17 2018-10-25 Miron Oren Auditory brainstem response for autism prediction
EP3684463B1 (en) 2017-09-19 2025-05-14 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement
US11717686B2 (en) 2017-12-04 2023-08-08 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to facilitate learning and performance
US12280219B2 (en) 2017-12-31 2025-04-22 NeuroLight, Inc. Method and apparatus for neuroenhancement to enhance emotional response
US11478603B2 (en) 2017-12-31 2022-10-25 Neuroenhancement Lab, LLC Method and apparatus for neuroenhancement to enhance emotional response
US11364361B2 (en) 2018-04-20 2022-06-21 Neuroenhancement Lab, LLC System and method for inducing sleep by transplanting mental states
US11426073B2 (en) * 2018-04-27 2022-08-30 Washington University Imaging nerve function and pathologies using diffusion basis spectrum imaging
CN113382683A (zh) 2018-09-14 2021-09-10 纽罗因恒思蒙特实验有限责任公司 改善睡眠的系统和方法
FI20185893A1 (fi) * 2018-10-23 2020-04-24 Elekta Oy Päähän asennettava laitteisto
EP3870030A4 (en) * 2018-10-23 2022-08-03 Blackthorn Therapeutics, Inc. SYSTEMS AND METHODS FOR SCREENING, DIAGNOSIS AND STRATIFICATION OF PATIENTS
WO2020186148A1 (en) 2019-03-13 2020-09-17 The Children's Hospital Of Philadelphia Methods for the detection of brain injury
US11786694B2 (en) 2019-05-24 2023-10-17 NeuroLight, Inc. Device, method, and app for facilitating sleep
US20220375082A1 (en) * 2019-11-15 2022-11-24 The University Of Chicago Cancer detection based on four quadrant mapping and matrix analysis of image data
US12521053B2 (en) * 2022-01-05 2026-01-13 Tdk Corporation Methods and devices for electromagnetic measurements from ear cavity

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2540295A1 (en) * 2011-06-27 2013-01-02 Centre national de la recherche scientifique Compositions for the treatment of Fragile X syndrome

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
GANDAL ET AL., "Validating oscillations and delayed auditory responses as translational biomarkers of autism.", BIOL PSYCHIATRY., (2010-12-15), vol. 68, no. 12, pages 1100 - 1106 *

Also Published As

Publication number Publication date
WO2014145382A8 (en) 2014-12-31
CA2907494C (en) 2022-10-04
EP2967405A4 (en) 2017-01-11
AU2014233048A1 (en) 2015-10-08
US10342480B2 (en) 2019-07-09
CA2907494A1 (en) 2014-09-18
WO2014145382A3 (en) 2014-10-30
EP2967405A2 (en) 2016-01-20
JP2016519595A (ja) 2016-07-07
JP6585030B2 (ja) 2019-10-02
WO2014145382A2 (en) 2014-09-18
US20160022207A1 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
AU2014233048B2 (en) Magnetoencephalography biomarkers of GABA-B agonist drug activity in autism spectrum disorders
Edgar et al. Neuromagnetic oscillations predict evoked-response latency delays and core language deficits in autism spectrum disorders
Grent et al. 40-Hz auditory steady-state responses characterize circuit dysfunctions and predict clinical outcomes in clinical high-risk for psychosis participants: a magnetoencephalography study
Roberts et al. Maturational differences in thalamocortical white matter microstructure and auditory evoked response latencies in autism spectrum disorders
Kim et al. Diagnostic utility of quantitative EEG in un-medicated schizophrenia
Javitt et al. Neurophysiological biomarkers for drug development in schizophrenia
Huneau et al. Altered dynamics of neurovascular coupling in CADASIL
Minshew et al. Neurologic aspects of autism
Hata et al. Functional connectivity assessed by resting state EEG correlates with cognitive decline of Alzheimer’s disease–An eLORETA study
Velikova et al. Dysfunctional brain circuitry in obsessive–compulsive disorder: source and coherence analysis of EEG rhythms
Edgar et al. Cortical thickness as a contributor to abnormal oscillations in schizophrenia?
Shin et al. Pre-attentive auditory processing in ultra-high-risk for schizophrenia with magnetoencephalography
Cromarty et al. Neurophysiological biomarkers for Lewy body dementias
Zhou et al. A modality‐specific dysfunction of pain processing in schizophrenia
Boshra et al. On the time-course of functional connectivity: theory of a dynamic progression of concussion effects
Wu et al. Resting-state electroencephalography of neural oscillation and functional connectivity patterns in late-life depression
Baumgarten et al. Connecting occipital alpha band peak frequency, visual temporal resolution, and occipital GABA levels in healthy participants and hepatic encephalopathy patients
Chen Cortical representation of pain and touch: evidence from combined functional neuroimaging and electrophysiology in non-human primates
Juan et al. Distinct signatures of loss of consciousness in focal impaired awareness versus tonic-clonic seizures
Bartolomeo et al. Relationship of auditory electrophysiological responses to magnetic resonance spectroscopy metabolites in Early Phase Psychosis
De Pieri et al. Resting-state EEG and MEG gamma frequencies in schizophrenia: a systematic review and exploratory power-spectrum meta-analysis
Staffen et al. Brain activation disturbance for target detection in patients with mild cognitive impairment: an fMRI study
Akkol et al. Intracranial electroencephalography reveals selective responses to cognitive stimuli in the periventricular heterotopias
Rupp et al. Abnormal error-related antisaccade activation in premanifest and early manifest Huntington disease.
Hoffmann et al. Visual pathways in humans with ephrin-B1 deficiency associated with the cranio-fronto-nasal syndrome

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)